RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. CaaS Capital Management
C

CaaS Capital Management portfolio

CaaS Capital Management has 3 portfolio companies on record at Recent Funding. Its most recent investment on record is HotSpot Therapeutics's $100M Series B+ round in November 2021, alongside Tekla Capital Management, SR One, Sofinnova Partners and 6 others. By category, its portfolio leans toward Health and bio (3) and Legal and compliance (1). It has co-invested with MRL Ventures Fund, Sofinnova Partners and Tekla Capital Management.

Type: Investor.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 0.
Capital in their rounds: $210M.
Latest deal: HotSpot Therapeutics · Nov 29, 2021.

What CaaS Capital Management invests in

How CaaS Capital Management invests

StageDealsCapital in rounds
Series B+ 2 100%$210M

Share is of the 2 rounds on Recent Funding that name CaaS Capital Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

CaaS Capital Management portfolio companies

CompanyRound with CaaS Capital ManagementTotal raisedLatest raise
HHotSpot Therapeutics
Legal and compliance
Series B+ · $100M$210MNov 29, 2021
Series B+
TT-Knife
Health and bio
Series B+ · $110M$188MAug 2, 2021
Series B+
UUmoja Biopharma
Health and bio
backer$363MJan 14, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists CaaS Capital Management, which is a subset of its real portfolio. API: /api/v1/investors/caas-capital-management (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy